efficacy
A new overview of systematic reviews of published randomized control trials of mobile health apps found just 23 RCTs of currently-available apps have been conducted, and less than half of those showed a positive health effect from the app in question.
Adherium, the Australian connected inhaler company that partnered with AstraZeneca earlier this summer, has released data from three small studies of the company's Smartinhaler system.